Daniel W. Elger
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Daniel W. Elger
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Sarossa Capital Ltd.
 Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom.
8
| Extinct | Financial Conglomerates | 8 |
| Public Company | Biotechnology | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Daniel W. Elger
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| VERNALIS | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
Artimplant AB
 Artimplant AB Medical SpecialtiesHealth Technology Artimplant AB engages in research and development of biomaterials for solutions to problems in orthopedic, odontological and reconstructive surgery. It also involves in the development, production and marketing of degradable implants designed to restore active lifestyles and improve quality of life. The company was founded by Anders Cedronius in 1990 and is headquartered in Vastra Frolunda, Sweden. | Medical Specialties | Director/Board Member | |
| NICOX SA | Pharmaceuticals: Major | Director/Board Member | |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Investment Managers | Chairman | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Glaxo Group Research Ltd. | General Counsel | ||
| PROBI AB | Biotechnology | Director/Board Member | |
| FLERIE INVEST AB | Pharmaceuticals: Major | Chairman | |
| PHOTOCURE ASA | Medical Specialties | Director/Board Member | |
| University of Uppsala | College/University | Graduate Degree | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| The International Institute for Conflict Prevention & Resolut | Corporate Officer/Principal | ||
MDS Pharma Services (Canada)
 MDS Pharma Services (Canada) Miscellaneous Commercial ServicesCommercial Services MDS Pharma Services provides contract drug discovery and drug development services for pharmaceutical and biotechnology companies. It provides its clients with early-stage, clinical research and late-stage drug discovery and development services, such as Phase I-IV testing, target discovery and lead optimization. The company is located in Saint-Laurent, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| RENEURON GROUP PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Antisoma Research Ltd. | Corporate Officer/Principal | ||
| REDX PHARMA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| WEIFA ASA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Hertfordshire | College/University | Undergraduate Degree | |
| Wingfirm Pharma AB | Director/Board Member | ||
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Chairman | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CELGENE | Biotechnology | Corporate Officer/Principal | |
| University of Cambridge | College/University | Graduate Degree | |
| OXFORD BIODYNAMICS PLC | Biotechnology | Director of Finance/CFO | |
| The UCL Academy | College/University | Undergraduate Degree | |
Aethon Therapeutics, Inc.
 Aethon Therapeutics, Inc. Hospital/Nursing ManagementHealth Services The company, co-founded by venture capital firm Apple Tree Partners and New York University cancer researchers Shohei Koide, Ph.D., and Benjamin G. Neel, Ph.D., unites immunotherapy and targeted therapy to expand the power and promise of both approaches for people living with cancer. Aethon Therapeutics, Inc. is based in New York, NY. Part of NYU Langone Medical Center, Aethon Therapeutics, Inc. is a company that creates neoantigens by design to transform cancer treatments into cures. The company's novel anti-drug-peptide conjugate/mhc antibodies are designed to be used in combination with targeted covalent inhibitors of ras, egfr, and other oncogenic driver mutations to mount immune attacks and selectively kill residual cancer cells, including drug-resistant "persister" cells. The company was founded by Benjamin G. Neel, Shohei Koide. The CEO is Rajesh Chopra. | Hospital/Nursing Management | Chief Executive Officer | |
Nereid Therapeutics, Inc.
 Nereid Therapeutics, Inc. BiotechnologyHealth Technology Nereid Therapeutics, Inc. operates as a life sciences venture firm. It translates the potential of biomolecular condensates into life-changing therapeutics. The company was founded by Clifford Brangwynne and Spiros Liras and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Apple Tree venture Managemnet Llc//vc
 Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Investment Managers | Private Equity Investor | |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| The Christie NHS Foundation Trust | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University College London | College/University | Doctorate Degree | |
| NANEXA AB | Medical Specialties | Director/Board Member | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
| VIVESTO AB | Pharmaceuticals: Generic | Director/Board Member | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Director/Board Member | |
| Navigation Dynamics AB | Director/Board Member | ||
| ADDLIFE AB | Medical/Nursing Services | Director/Board Member | |
| NEOS AB | Medical Specialties | Director/Board Member | |
| Parke-Davis AB | Chief Tech/Sci/R&D Officer | ||
| Astra Research Centre AB | Chief Tech/Sci/R&D Officer | ||
| EXINI DIAGNOSTICS AB | Packaged Software | Director/Board Member | |
| Jettesta AB | Director/Board Member | ||
| The University of Law Ltd. | College/University | Graduate Degree |
Statistik
International
| Schweden | 22 |
| Vereinigtes Königreich | 17 |
| Vereinigte Staaten | 8 |
| Norwegen | 4 |
| Frankreich | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 7 |
| Commercial Services | 4 |
| Finance | 3 |
| Technology Services | 3 |
Operativ
| Director/Board Member | 56 |
| Corporate Officer/Principal | 23 |
| Independent Dir/Board Member | 10 |
| President | 7 |
| Chief Executive Officer | 7 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Birgit Stattin Norinder | 29 |
| Dale J. Boden | 18 |
| Ursula Ney | 16 |
| Rajesh Chopra | 10 |
| Ann V. Hacker | 8 |
| Steven Medlicott | 8 |
| Nicholas Adams | 7 |
| Gary Acton | 4 |
| Paul Stockdale | 4 |
| John Mark Cordiner | 3 |
| Kevin Kissane | 3 |
| Chris Smyth | 3 |
- Börse
- Insiders
- Daniel W. Elger
- Unternehmensverbindungen
